Expression of long non coding RNA H19& miR-675 in colorectal cancer and ulcerative colitis patients

Author:

Sobhy Rania1,Shaker Olfat2,Khairy Ahmed3,Gaber Dalia A.1

Affiliation:

1. Helwan University

2. Cairo University

3. Cairo University Kasr Alainy Faculty of Medicine

Abstract

Abstract Background: Colorectal cancer (CRC) is a growing public health problem and has been stretching in the recent years from old age group to encompass younger age group. Inflammatory bowel disease like ulcerative colitis is a risk factor for CRC. Aim: Test the expression of microRNA- 675 (miR-675) and long non coding RNA H19 (Lnc H19) for their diagnostic & prognostic potential in CRC. Methodology: A prospective cross-sectional study was conducted on 60 patients with CRC, 60 patients with UC as well as 30 control subjects. miR-675 & lnc H19 were quantified by real time RT-PCR. Lab investigations and radiological investigations were also performed and correlated with the genetic biomarkers. Results: Lnc H19 was highly expressed in both CRC and UC groups with a statistically significant difference from the control group. There was a significant enhanced expression of H19 in CRC compared to UC group. Although miRNA -675 was down regulated in both UC and CRC groups but it was more expressed in CRC compared to UC group. Conclusion: According to our results we can conclude that H19 can be considered as potential non-invasive biomarker for diagnosis of UC and early detection of CRC

Publisher

Research Square Platform LLC

Reference42 articles.

1. Global colorectal cancer burden in 2020 and projections to 2040;Xi Y;Transl Oncol,2021

2. BMAL1 Knockdown Leans Epithelial–Mesenchymal Balance toward Epithelial Properties and Decreases the Chemoresistance of Colon Carcinoma Cells;Zhang Y;Int J Mol Sci,2021

3. Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer;Mármol I;Int J Mol Sci,2017

4. Management of Metastatic unresectable disease of colorectal cancer origin (Part 1: cytotoxic therapy);Abdulla M;Res in Oncol,2013

5. Cancer Antigens (CEA and CA 19 – 9) as Markers of Advanced Stage of Colorectal Carcinoma;Vukobrat-Bijedic Z;Med Arch,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3